Renal Nerve Stimulation and Renal Denervation in Patients with Sympathetic Ventricular Arrhythmias - Redress VT

Isala Klinieken0 个研究点目标入组 60 人开始时间: 待定最近更新: 2024年6月11日

试验速览

暂无简介。

•Patients with recurrent sympathetic ventricular arrhythmia despite optimal pharmacological therapy.
•Patients with CPVT or certain types of long QT syndrome, ARVC, HCM, DCM or ICM. Patients should use adequate beta-blocker dose or should be intolerant for anti-arrhythmic medication.
•Patient is an acceptable candidate for renal denervation treatment
•Patient is 18-85 years of age
•Documentation of ventricular arrhythmia (ECG, rhythm strip or ICD interrogation)

•Contraindication to anticoagulation therapy or heparin.
•Previous selective cardiac sympathetic denervation or previous renal denervation procedure.
•Acute coronary syndrome, cardiac surgery, PCI or stroke within 3 months prior to enrolment.
•Untreated hypothyroidism or hyperthyroidism.
•More than grade 1/3 valvular regurgitation and/or significant valve stenosis (moderate or severe).
•Severe LV dysfunction (LVEF <20% and/or grade 3/4 diastolic dysfunction)
•Planned cardiovascular intervention.
•Renal artery stenosis >50% of the arterial lumen, or renal artery lumen <=3 mm.

发起方

Isala Klinieken